Newsfeeds - Spark Newswire

2 minute read

OKYO Pharma Limited Prices $5.3M Offering Of 3,503,665 ADSs At A Price Of $1.50/ADS

March 14, 9:25 AM

OKYO Pharma Limited (NASDAQ:OKYO) (LSE: OKYO) (“OKYO Pharma” or the “Company“), a biotechnology company focused on the discovery and development of novel molecules to treat inflammatory

OKYO

2 minute read

Why PacWest Bancorp Shares Are Trading Higher By 30%; Here Are 20 Stocks Moving Premarket

By Lisa Levin

March 14, 8:03 AM

Gainers PacWest Bancorp (NASDAQ: PACW) rose 29.9% to $12.66 in pre-market trading after multiple insider buys by Officers, Directors reported late Monday.

AMLX

1 minute read

OKYO Pharma Announces $5.74M Private Placement And Investment By Directors, Senior Management Members

By Benzinga Newsdesk

March 14, 4:34 AM

OKYO will issue 3,503,665 new ADSs (representing 227,738,225 new Ordinary Shares) ("New ADSs") to certain investors at a price of U.S.$1.50 per New ADS ("U.S. Offering Price") raising gross

OKYO

3 minute read

Why Novavax Shares Are Trading Lower By Around 28%? Here Are Other Stocks Moving In Wednesday’s Mid-Day Session

By Lisa Levin

March 1, 2:16 PM

Gainers Reata Pharmaceuticals Inc (NASDAQ: RETA) shares jumped 171.5% to $84.67 after the company reported the FDA approval of SKYCLARYS for patients with Friedreich's Ataxia.

ADMP

2 minute read

3D Systems, CarGurus, Sarepta Therapeutics And Other Big Stocks Moving Higher On Wednesday

By Lisa Levin

March 1, 11:18 AM

U.S. stocks traded lower, with the Dow Jones dropping around 80 points on Wednesday. Here are some big stocks recording gains in today’s session.

AMPH

1 minute read

US Customs Clears OKYO Pharma’s GMP Packaged OK-101 Drug For Phase 2 Clinical Trial for Treating Dry Eye Disease

By Benzinga Newsdesk

February 28, 3:47 AM

OKYO Pharma Limited ((LSE: OKYO, NASDAQ:OKYO), an ophthalmology-focused bio-pharmaceutical company which is developing OK-101 to treat dry eye disease (DED) to address the significant unmet need in this

OKYO

4 minute read

Why CVRx Shares Are Trading Lower By 43%? Here Are Other Stocks Moving In Tuesday’s Mid-Day Session

By Lisa Levin

February 21, 3:07 PM

Gainers Arbe Robotics Ltd. (NASDAQ: ARBE) gained 62.8% to $7.08. Arbe Robotics is expected to report its financial results for the fourth quarter on Thursday, March 2, 2023.

AKAN

3 minute read

Nasdaq Drops Over 100 Points; Walmart Issues Cautious Forecast

By Lisa Levin

February 21, 11:15 AM

U.S. stocks traded lower this morning, with the Nasdaq Composite dropping more than 100 points on Tuesday. Following the market opening Tuesday, The Dow traded down 1.15% to 33,438.86 while the NASDAQ fell 1.24% to 11,640.85. The S&P 500 also fell, dropping, 1.03% to 4,037.11.

ALRN